Abstract:Objective To investigate the application value of susceptibility weighted imaging (SWI) combined with platelet distribution width (PDW) in intravenous thrombolysis for treatment of patients with acute cerebral infarction (ACI). Methods One hundred and ten patients with ACI treated by intravenous thrombolysis admitted to the Department of Radiology of the Second Affiliated Hospital of Medical College of Zhejiang University from February 2017 to June 2018 were enrolled as the subjects. Before treatment, all patients were detected by routine magnetic resonance imaging (MRI), SWI scanning and PDW detection. The patients were divided into hemorrhage group (77 cases) and non-hemorrhage group (33 cases) according to the presence or absence of hemorrhage shown in SWI, and according to the amount of bleeding, the hemorrhage group patients were subdivided into light (24 cases), medium (32 cases) and severe (21 cases) three groups. After intravenous thrombolysis, the patients were scanned by SWI to show whether bleeding being present or not, the cerebral microbleeding (CMBs) after 24 hours treatment in two groups, and after treatment of 14 days, modified Rankin score (MRS), PDW and hemorrhagic transformation (HT) situation in the two groups were evaluated and compared, the differences in hemorrhagic infarction 1 (HI1), hemorrhagic infarction 2 (HI2), parenchymal hemorrhage 1 (PH1) and parenchymal hemorrhage 2 (PH2) in different bleeding volume groups were compared. Results Before treatment, 129 lesions detected by SWI were significantly greater than 14 lesions detected by T1 weighted imaging, 22 lesions detected by T2 weighted imaging and 86 lesions detected by diffusion weighted imaging. After treatment for 24 hours, the number of CMBs (number: 10 vs. 0), after treatment for 14 days, the incidence of HT [36.36% (28/77) vs. 12.12% (4/33)], MRS (1.78±0.39 vs. 1.51±0.42) and PDW [(12.34±5.29)% vs. (6.79±3.27)%] in the hemorrhagic group were higher than those in non-hemorrhagic group (all P < 0.05). After treatment of 14 days, the incidences of HT [71.43% (15/21) vs. 20.83% (5/24), 25.00% (8/32)], PDW [(14.52±4.11)% vs. (10.78±3.67)%, (11.34±3.89)%] in severe group were higher than those in light group and moderate groups (all P < 0.05), and the rate of good prognosis was significantly lower than those in mild and moderate groups [42.86% (9/21) vs. 70.83% (17/24), 71.88% (23/32), P < 0.05]. The incidence of HT in severe group was also significantly higher than those in the non-hemorrhage group [71.43% (15/21) vs. 11.76% (4/34), P < 0.05]. Conclusion SWI combined with PDW can guide the intravenous thrombolysis very well for patients with ACI, and has relatively high clinical value.

Clinical Observation on Effect of Intervention Therapy with Anticoagulant in Treating Patients of Hypertension Complicated with Acute Ischemic Cerebrovascular Disease

Clinical study of cerebral infarction prevention with warfarin in nonvalvular atrial fibrillation

A study on application value of susceptibility weighted imaging combined with platelet distribution width in intravenous thrombolysis for treatment of patients with acute cerebral infarction

Effect and safety of rt-PA combined with Hydroxyethyl starch in the treatment of acute cerebral infarction

The Clinical Observation Of Anticoagulants And Antithrombotic Therapy In Elderly Patients With Atrial Fibrillation

Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction

Effect of Hyperbaric Oxygen Combined with Ganglion Glycosides on Thrombin, Serum Myelin Basic Protein and D-dimer in Patients with Intracerebral Hemorrhage

Effects of tirofiban on non-ST-segment elevation acute myocardial infarction

Clinical observation of Salviae Miltiorrhizae and Ligustrazine Hydrochloride Injection combined with atorvastatin in treatment of acute cerebral infarction

Effect of Comprehensive Nursing Intervention on the Effect of CT-Guided Intravenous Thrombolysis in Acute Cerebral Infarction

Clinical Observation of Acute Cerebrovascular Disease Complicated with Cerebrocardiac Syndrome

Clinical efficacy and the influence of fibrinogen, homocysteine and prognosis in acute ischemic stroke patients treated with tirofiban plus TERVO stent thrombectomy

Effect of intravenous thrombolysis combined with endovascular treatment on vascular recanalization rate and peak systolic velocity in patients with acute cerebral infarction

Clinical Observation on Jianpihuoxuetang in Treating Patients with Vertebrobasilar Insufficiency

Analysis of Curative Effect and Prognosis of Intracranial Vascular Interventional Therapy for Ischemic Cerebrovascular Disease

The Effects of Ticagrelor Combined with Tirofiban on Coagulation Function, Serum Myocardial Injury Markers, and Inflammatory Factor Levels in Patients with Acute Myocardial Infarction after Percutaneous Coronary Intervention

Clinical Effect of Amlodipine Besylate Tablets Combined with Simvastatin Tablets in Treating Coronary Heart Disease Patients Complicated with Cerebral Infarction and the Impact on Serum Levels of TIMP-1,MMP-9 and sCD40L

The Changes of Blood Lipids, Coagulation and Fibrinolysis Indices in Patients with Ischemic Cerebrovascular Dissease

Clinical Efficacy of Yinxingdamo Injection Combined with Antithrombotic Therapy for Treating the Patients with Acute Coronary Syndrome

Comparison of the therapeutic effect between interventional treatment and anticoagulation therapy alone in patients with intracranial venous sinus thrombosis

Efficacy and Security of Promoting-Circulation Drug Combined with Aspirin in Therapy of Cerebral Infarction Patients